← Leaderboards
Carla Maria Pedrosa Ribeiro
Univ Of North Carolina Chapel Hill
$2,769,732
Attributed
$3,283,544
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $464.6K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,283,544 · 4
By mechanism
R01$1,848,920 · 1
R41$599,999 · 1
R56$427,625 · 1
R21$407,000 · 1
Top collaborators
- Emily Arthur Hull-Ryde2 shared
- Martina Gentzsch1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Miriam S. Braunstein$8,640,200
- Chengwen Li$10,504,911
- Samuel Lai$12,082,303
- Nigel S Key$14,906,926
- Richard J Samulski$19,583,832
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsMediatingEndoplasmic ReticulumBronchial EpitheliumMucous Body SubstanceMucinsAirway InflammationEndoplasmic Reticulum StressEnzymesAirway EpitheliumInositolCytokineAsthmaProductionExhibitsProtein IsoformsObstructionCystic FibrosisCystic Fibrosis AirwayMuc5b GeneLeadMessenger RnaBinding Proteins
Grant awards (9)
Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production$455,261
R01 · FY2024 · HL · contact PI
Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production$464,553
R01 · FY2023 · HL · contact PI
Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production$464,553
R01 · FY2022 · HL · contact PI
Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production$464,553
R01 · FY2021 · HL · contact PI
IRE1beta Inhibitors: Novel Therapeutics to Manage Excess Mucus in Asthma$299,999
R41 · FY2020 · AI
IRE1beta Inhibitors: Novel Therapeutics to Manage Excess Mucus in Asthma$300,000
R41 · FY2019 · AI
Rescued CFTR Function in Preclinical Models of Airway Epithelial Inflammation$427,625
R56 · FY2018 · HL · contact PI
IRE1beta: A Novel Pathway for Regulation of Airway Epithelial Mucin Production$185,000
R21 · FY2011 · HL · contact PI
IRE1beta: A Novel Pathway for Regulation of Airway Epithelial Mucin Production$222,000
R21 · FY2010 · HL · contact PI